Document is current
Any future updates will be listed below
-
Authors
Schmitz, Sarah H. https://orcid.org/0000-0002-4993-8978
Aronne, Louis J. https://orcid.org/0000-0002-9890-9401
- License Information
-
More Information
Article History
First Online: 7 October 2025
Competing interests
: L.J.A. has received research funding from Eli Lilly, Novo Nordisk, Altimmune and Skye Bioscience. He has received consulting fees from Boehringer-Ingelheim, Currax Pharmaceuticals, Eli Lilly, Altimmune, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Novo Nordisk, Pfizer, Veru Pharmaceuticals, Zealand Pharmaceuticals and Amgen. He has received payment or honoraria for lectures for Boehringer-Ingelheim, Skye Bioscience, Zealand Pharmaceuticals, Jamieson Wellness and Pfizer. He holds leadership roles at FlyteHealth, Jamieson Wellness and ERX Pharmaceuticals. He has stock or stock options in Jamieson Wellness, FlyteHealth, Kallyope, Mediflix, MBX Bioscience, Syntis, Veru Pharmaceuticals and Skye Bioscience. S.H.S. declares no competing interests.
